Caixin
Feb 27, 2024 06:16 AM
OPINION

Commentary: What is Needed to Bolster China’s Biopharma Innovation

00:00
00:00/00:00
Listen to this article 1x
Since 2011, China has green-lighted 510 new drugs, a third of which were homegrow
Since 2011, China has green-lighted 510 new drugs, a third of which were homegrow

The push for innovation in the biopharmaceutical industry and its continuing development are urgent tasks. This sector is pivotal for China’s future, a key strategic field that can help drive modernization and offers vast potential for expansion. It is an industry that mirrors China’s increasing scientific prowess and is crucial to sustain high-quality economic progress.

loadingImg
You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code